Hairstetics

Company Overview

Snapshot

Founded in April 2010 by Boaz Shenhav and Dvir Keren, Hairstetics operates with 1–10 employees. The company has raised $7.42M across 5 funding rounds from 3 investors.

Business overview

Hairstetics develops state-of-the-art hair implants, focusing on a non-surgical, minimally invasive solution for alopecia and hair loss. Their core product, the Hairstetics Hair Implant Device, is a multiple-hair implantation device with an anchoring system designed for quick, in-office procedures. The company initially targets women with androgenetic alopecia, with plans to expand to all alopecia-affected populations, providing user-friendly devices for physicians in the Medical Treatment & Therapeutics sector.

Strategic signal

In October 2025, Hairstetics announced the expansion of its patented medical procedure for minimally invasive synthetic hair implantation. This development signals a strategic move to scale its unique non-surgical hair restoration treatment, particularly for female hair loss, indicating strong commercial momentum and a commitment to addressing a significant market need within the medical aesthetics industry.

Company Intelligence Q&A

What is Hairstetics' primary focus?

Hairstetics focuses on developing a non-surgical, no-downtime hair restoration system, specifically a multiple-hair implantation device with an anchoring system, primarily for treating alopecia and hair loss in women.

What significant recognition did Hairstetics receive?

In September 2021, Hairstetics was awarded the IMCAS prize for innovation in aesthetic medicine.

Which investor has frequently participated in Hairstetics' funding rounds?

Peregrine Ventures has participated in multiple funding rounds for Hairstetics, including investments in November 2023, September 2022, and June 2018.

What was a key strategic announcement by Hairstetics in late 2025?

In October 2025, Hairstetics announced the scaling of its minimally invasive synthetic hair implant treatment for female hair loss, expanding its award-winning, patented medical procedure.